Breast Implants Linked To Rare Cancer Recalled Worldwide
Medical device-maker Allergan is recalling one of its breast implants two weeks after Australia's regulatory body said it was banning the product because of a link to a rare form of cancer.
The Therapeutic Goods Administration's proposed regulatory action on July 11 following a review of an apparent association between anaplastic large cell lymphoma and some implants.
Allergan Australia said then it was reviewing the TGA action in relation to its Natrelle Biocell textured breast implants and tissue expanders.
On Thursday, Allergan issued a worldwide recall for the implants.
"Effective immediately, healthcare providers should no longer implant new Bio Cell textured breast implants and tissue expanders and unused products should be returned to Allergan," the company said in a statement on Thursday.
Photo: Getty images
"Regulatory bodies around the world including the TGA have not recommended removal or replacement of textured breast implants or tissue expanders in asymptomatic patients," the statement continued.
Australia's peak body for cosmetic surgeons also said there was no cause for alarm for people who have the breast implants, and to consider all evidence before taking action.
The Australasian College of Cosmetic Surgery said the risks of developing a cancer that spreads is extremely small.
The risk of breast implant-associated lymphoma sits between one-in-1000 and one-in-10,000.
As of May, Australian regulators had received 78 reports of anaplastic large cell lymphoma associated with breast implants, including four deaths.